2m 2m 2m 2m 2m 2m 2m
Inhibitor Therpt (INTI)
OTC
$0.08-$0.001 (-1.76%)
Price as of Jun 02, 2026- $14.7MMarket Cap
- 92.09%1-Year Change
- BiotechnologyIndustry
Inhibitor Therpt (INTI)
$0.08-$0.001 (-1.76%)
INTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.08 | ||
Change | -$0.001 (-1.76%) | ||
Open | $0.08 | ||
High | $0.08 | ||
Low | $0.08 | ||
Previous Close | $0.09 | ||
Volume | 1,242 | ||
30-Day Average Volume | 31,222 | ||
1-Week Change | 8.44% | ||
1-Month Change | -7.22% | ||
1-Year Change | 92.09% | ||
3-Year Change | 160.94% | ||
5-Year Change | -99.06% | ||
Fundamentals | |||
Shares Outstanding | 172.6M | ||
Total Assets | $1.4M | ||
Market Cap | $14.7M | ||
Enterprise Value | $13.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.1M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $993,633.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -7 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue